Antileukotriene Agents Versus Long‐Acting Beta‐Agonists in Older Adults with Persistent Asthma: A Comparison of Add‐On Therapies

Altawalbeh, Shoroq M.; Thorpe, Carolyn T.; Zgibor, Janice C.; Kane‐Gill, Sandra L.; Kang, Yihuang; Thorpe, Joshua M.

doi:10.1111/jgs.14235

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Antileukotriene Agents Versus Long‐Acting Beta‐Agonists in Older Adults with Persistent Asthma: A Comparison of Add‐On Therapies

Abstract: This study provides new evidence specific to older adults to help healthcare providers weigh the risks and benefits of these add-on treatments. Further subgroup analysis is needed to personalize asthma treatments in this high-risk population.

Cited by 3 publications

References 40 publications

A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma

A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma

Management of patients with asthma or COPD and cardiovascular disease: risksversusbenefits

Economic Burden Associated with Receiving Inhaled Corticosteroids with Leukotriene Receptor Antagonists or Long-Acting Beta Agonists as Combination Therapy in Older Adults

Contact Info

Product

Resources

About